Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (421-430 of 522) with videos related to

Pageof 53
Sort By:
Clinical Genitourinary Cancer|July 2, 2019
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?Kae Jack Tay, Thomas J Polascik, Lauren E Howard, et al.
The Prostate|March 11, 2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world populationHanson Zhao, Lauren E Howard, Amanda M De Hoedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 19, 2026
Marital status and post-radical prostatectomy outcomes: results from the SEARCH databaseAlanna Burwell, Jaruda Ithisuphalap, Jessica L Janes, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2022
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?Zachary Klaassen, Lauren Howard, Christopher J D Wallis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer riskK J Aronson, A B Miller, C G Woolcott, et al.
Plos One|October 7, 2016
Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the BoneSandy Liu, Radu M Cadaneanu, Baohui Zhang, et al.
Cancer Causes & Control : CCC|July 5, 2023
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH CohortIvy T Liu, Lin Gu, Amanda M De Hoedt, et al.
Prostate Cancer and Prostatic Diseases|April 11, 2024
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohortMahdi Mottaghi, Lin Gu, Sriram Deivasigamani, et al.
Transplantation|August 5, 2000
Combined liver and kidney transplantation in childrenH P Grewal, L Brady, D C Cronin, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Pageof 53

Showing results (421-430 of 522) with videos related to

Sort By:
Pageof 53
Clinical Genitourinary Cancer|July 2, 2019
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?Kae Jack Tay, Thomas J Polascik, Lauren E Howard, et al.
The Prostate|March 11, 2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world populationHanson Zhao, Lauren E Howard, Amanda M De Hoedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 19, 2026
Marital status and post-radical prostatectomy outcomes: results from the SEARCH databaseAlanna Burwell, Jaruda Ithisuphalap, Jessica L Janes, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2022
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?Zachary Klaassen, Lauren Howard, Christopher J D Wallis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer riskK J Aronson, A B Miller, C G Woolcott, et al.
Plos One|October 7, 2016
Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the BoneSandy Liu, Radu M Cadaneanu, Baohui Zhang, et al.
Cancer Causes & Control : CCC|July 5, 2023
Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH CohortIvy T Liu, Lin Gu, Amanda M De Hoedt, et al.
Prostate Cancer and Prostatic Diseases|April 11, 2024
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohortMahdi Mottaghi, Lin Gu, Sriram Deivasigamani, et al.
Transplantation|August 5, 2000
Combined liver and kidney transplantation in childrenH P Grewal, L Brady, D C Cronin, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
Pageof 53